The Triangle’s Emerging Biotech Powerhouse
Holly Springs: The Triangle’s Emerging Biotech Powerhouse
Holly Springs is rapidly transforming from a quiet suburban town into a major biotech hub, thanks to two massive developments from industry giants Amgen and Fujifilm Diosynth Biotechnologies. These projects are bringing cutting-edge technology, high-paying jobs, and economic growth to the area, solidifying its status as a key player in North Carolina’s booming life sciences sector.
Amgen Facility: One of the world’s largest biotechnology companies, Amgen, is investing nearly $550 million in a new biomanufacturing facility in Holly Springs. This site will focus on producing innovative medicines using advanced automation and sustainable manufacturing techniques. The facility is expected to create 355 new jobs, drawing skilled professionals and researchers to the region.
Fujifilm Diosynth Biotechnologies: Already a significant presence in the area, Fujifilm is expanding its footprint with a $2 billion biomanufacturing plant, which will be one of the largest cell culture manufacturing sites in North America. The facility will specialize in producing biologic medicines and is projected to employ more than 725 workers once fully operational.
These investments are reshaping Holly Springs into a biotech powerhouse, attracting talent and supporting local businesses. The town is seeing increased demand for housing, retail, and infrastructure improvements to accommodate the growth. With more companies eyeing the Triangle for expansion, Holly Springs is positioning itself as a leader in North Carolina’s life sciences boom, making it one of the most exciting places to watch in 2025.
